" title="West Pharmaceutical Services to Present at the CJS 25th Annual “New Ideas for the New Year” Investor Conference
EXTON, Pa., Jan. 6, 2025 /PRNewswire/ — West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark, Sr. VP and Chief Commercial Officer; Chad Winters, VP of Finance and Chief Accounting Off
JEGI CLARITY Has Advised Hart Energy on Their Sale of Rextag to Yellow Point Equity Partners
NEW YORK, Jan. 6, 2025 /PRNewswire/ — Hart Energy, advised by JEGI CLARITY, has sold Rextag to Yellow Point Equity Partners. Founded in 2006, Rextag provides the largest and most complete mapping and data solutions related to energy infrastructure assets in the US market. The Company licenses
MGIC Investment Corporation Schedules 4th Quarter 2024 Earnings Call
MILWAUKEE, Jan. 6, 2025 /PRNewswire/ — MGIC Investment Corporation (NYSE: MTG) has announced plans to release its fourth quarter 2024 financial results after the market closes on Monday, February 3, 2025. A conference call/webcast has been scheduled for 10:00 a.m. Eastern Time on Tuesday, Fe
Lam Research Corporation Announces December Quarter Financial Conference Call
FREMONT, Calif., Jan. 6, 2025 /PRNewswire/ — Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, January 29, 2025, beginning at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time). Webcast:
Waystar to Present at J.P. Morgan Healthcare Conference
LEHI, Utah and LOUISVILLE, Ky., Jan. 6, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13,
Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 6, 2025 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian,
Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 6, 2025 /PRNewswire/ — Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced that the Company will participate at the 43rd Annual J.P. Morgan
Agree Realty Announces 2024 Investment Activity & 2025 Investment Outlook
2025 Investment Guidance of $1.1 Billion to $1.3 BillionBalance Sheet Pre-Equitized with Liquidity of Over $2.0 Billion ROYAL OAK, Mich., Jan. 6, 2025 /PRNewswire/ — Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced a summary of its investment activity in 2024, i
Rexford Industrial Announces Dates for Fourth Quarter 2024 Earnings Release and Conference Call
LOS ANGELES, Jan. 6, 2025 /PRNewswire/ — Rexford Industrial Realty, Inc. (the “Company” or “Rexford Industrial”) (NYSE: REXR), a real estate investment trust focused on creating value by investing in and operating industrial properties located throughout infill Southern
Marcelo Claure and Harvard Growth Lab to Develop New Research Agenda to Diagnose the Current Crisis and Drive Economic Growth in Bolivia
CAMBRIDGE, Mass., Jan. 6, 2025 /PRNewswire/ — Bolivian-American entrepreneur Marcelo Claure and the Growth Lab at Harvard Kennedy School are launching a transformative research initiative to diagnose Bolivia’s economic challenges and propose strategic policy solutions for sustainable and
